Modeling the Development of <i>SRSF2</i> Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Gabriel Pabst(Research Institute of Molecular Pathology), Andreas Reinisch(Stem Cell Institute), Hildegard Greinix(Medical University of Graz), Johannes Foßelteder(Medical University of Graz), Peter Schlenke(Medical University of Graz), Karl Kashofer(Medical University of Graz), Armin Zebisch(Medical University of Graz), Heinz Sill(Medical University of Graz), Albert Woelfler(University of Graz), Ravindra Majeti(Stanford University), Lisa Auinger(Medical University of Graz), Angelika Schlacher(Medical University of Graz), Asiri Ediriwickrema(Stanford University), Christine Beham‐Schmid(Medical University of Graz), Daniel Martinez-Krams
Cited by 4
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
|Nature Genetics|2016|1.3k
Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation
|Cell|2018|777
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
|Science Translational Medicine|2012|723